Copyright © 2015 Andrés F. Echeverri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We present a 74-year-old female patient who developed a pityriasis lichenoides chronica (PLC) during etanercept therapy. This association is not described in the literature and might be considered in the spectrum of cutaneous adverse reactions of etanercept. 1
Etanercept is an inhibitor of the pro-inflammatory and immunor-egulatory cytokine tumor necrosis fac...
Hemophagocytic syndrome (HPS) is a severe, potentially life-threatening disorder characterized by an...
Background: With recent advancements in the understanding of psoriasis, treatment has evolved toward...
We present a 74-year-old female patient who developed a pityriasis lichenoides chronica (PLC) during...
Introduction : Pityriasis licehnoides (PL) exhibits a protean clinical presentation, particularly in...
Herein, we present three cases of Pityriasis lichenoides chronica (PLC) in patients who developed th...
Background: Lymphomatoid drug reactions can mimic endogenous T and B cell lymphoproliferative diseas...
Etanercept is a competitive inhibitor of tumor necrosis factor-alpha (TNF-α) a polypeptide hormone, ...
Three patients with atypical courses and manifestations of pityriasis lichenoides chronica (PLC) are...
Background \ud We report a case of a 53 year old lady recently commenced on etanercept, an anti-TNF ...
Hemophagocytic syndrome (HPS) is a severe, potentially life-threatening disorder characterized by an...
Copyright © 2014 Maŕıa Clara Ortiz-Sierra et al.This is an open access article distributed under th...
Acute generalized exanthematous pustulosis (AGEP) is a skin eruption that is primarily drug induc...
Tumor necrosis factor-alpha (TNF-α) is a proinflammatory cytokine produced predominantly by activate...
Certolizumab is a monoclonal antibody against tumour necrosis factor-alpha (TNF-α) commonly used in ...
Etanercept is an inhibitor of the pro-inflammatory and immunor-egulatory cytokine tumor necrosis fac...
Hemophagocytic syndrome (HPS) is a severe, potentially life-threatening disorder characterized by an...
Background: With recent advancements in the understanding of psoriasis, treatment has evolved toward...
We present a 74-year-old female patient who developed a pityriasis lichenoides chronica (PLC) during...
Introduction : Pityriasis licehnoides (PL) exhibits a protean clinical presentation, particularly in...
Herein, we present three cases of Pityriasis lichenoides chronica (PLC) in patients who developed th...
Background: Lymphomatoid drug reactions can mimic endogenous T and B cell lymphoproliferative diseas...
Etanercept is a competitive inhibitor of tumor necrosis factor-alpha (TNF-α) a polypeptide hormone, ...
Three patients with atypical courses and manifestations of pityriasis lichenoides chronica (PLC) are...
Background \ud We report a case of a 53 year old lady recently commenced on etanercept, an anti-TNF ...
Hemophagocytic syndrome (HPS) is a severe, potentially life-threatening disorder characterized by an...
Copyright © 2014 Maŕıa Clara Ortiz-Sierra et al.This is an open access article distributed under th...
Acute generalized exanthematous pustulosis (AGEP) is a skin eruption that is primarily drug induc...
Tumor necrosis factor-alpha (TNF-α) is a proinflammatory cytokine produced predominantly by activate...
Certolizumab is a monoclonal antibody against tumour necrosis factor-alpha (TNF-α) commonly used in ...
Etanercept is an inhibitor of the pro-inflammatory and immunor-egulatory cytokine tumor necrosis fac...
Hemophagocytic syndrome (HPS) is a severe, potentially life-threatening disorder characterized by an...
Background: With recent advancements in the understanding of psoriasis, treatment has evolved toward...